Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Cobolimab and Dostarlimab for the Treatment of BCLC Stage B or C Liver Cancer

Trial Status: closed to accrual

This phase II trial tests whether cobolimab and dostarlimab work to shrink tumors in patients with BCLC stage B or C liver cancer. Immunotherapy with monoclonal antibodies, such as cobolimab and dostarlimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.